PSYG Share Price Performance
CA$0.15
-0.07 (-33.33%)
Price CA$0.15
Share PriceCA$0.15
Psyence Group Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
PSYG Community Narratives
There are no narratives available yet.
Recent PSYG News & Updates
Psyence Group Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.85
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Psyence Group Inc. Competitors
Snowflake Analysis
About PSYG
- Founded
- 2019
- Employees
- n/a
- CEO
- WebsiteView website
Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. It also focuses on the research and development, cultivation, and production of psilocybin mushrooms and functional over-the-counter mushroom products. The company offers its functional mushroom products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Canadian Market Performance
- 7 Days: 0.4%
- 3 Months: 10.0%
- 1 Year: 21.2%
- Year to Date: 19.9%
In the last week, the market has been flat. Meanwhile, the market is actually up 21% over the past year. Looking forward, earnings are forecast to grow by 12% annually. Market details ›